Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
12.79
-2.21 (-14.73%)
At close: Sep 10, 2026, 4:00 PM EDT
12.75
-0.04 (-0.31%)
After-hours: Sep 10, 2026, 7:52 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.93 billion as of September 10, 2026. Its market cap has increased by 26.11% in one year.
Market Cap
1.93B
Enterprise Value
1.96B
1-Year Change
26.11%
Ranking
Category
Stock Price
$12.79
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.93B, an increase of 638.54%. That is a compound annual growth rate of 65.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 1.93B | 28.96% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precigen | 2.43B |
| Vera Therapeutics | 2.43B |
| Harmony Biosciences Holdings | 2.42B |
| Trevi Therapeutics | 2.37B |
| Sarepta Therapeutics | 2.33B |
| Nuvation Bio | 2.29B |
| UroGen Pharma | 2.20B |
| Palvella Therapeutics | 2.18B |